{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:38:39Z","timestamp":1788824319741,"version":"build-2803163510"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This manuscript addresses high-yield topics related to sexual and reproductive health (SRH) in adolescents and young women with inflammatory bowel disease (IBD) including puberty, menstruation, contraception, fertility, pregnancy, preventive care, and counseling strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Adolescent and young women with IBD are at risk for delayed puberty, menstrual cycle disorders, unintended pregnancy, and cervical cancer. Active disease or a history of intra-abdominal surgery can negatively impact fertility and pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>With appropriate screening, counseling and education, and shared decision making, providers can optimize both IBD and SRH outcomes. Further research in needed to specifically understand the role of pre-conception counseling in the adolescent setting, optimal management of menstrual cycle disorders in women with IBD, and the safety of newer medications during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11894-026-01032-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:00:40Z","timestamp":1770969640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reproductive Health in Young and Adolescent Females with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Erica J.","family":"Brenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca A.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Berenblum Tobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilia","family":"Kamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhya","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary K.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"1032_CR1","unstructured":"IBD Facts and Stats. 2024 [updated June 21, 2024. Available from: https:\/\/www.cdc.gov\/inflammatory-bowel-disease\/php\/facts-stats\/index.html"},{"key":"1032_CR2","unstructured":"Miller MHWALGPSH. Cascading harms: how abortion bans lead to discriminatory care across medical specialties. Research Brief. Physicians for Human Rights; 2025. September 2025."},{"key":"1032_CR3","unstructured":"Jorge AALGA, Dattani MT, Baron J. In: MA S, editor. Sperling pediatric endocrinology. 5 ed. Philadelphia: Elsevier; 2021."},{"issue":"3","key":"1032_CR4","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.beem.2019.04.009","volume":"33","author":"KT Kao","year":"2019","unstructured":"Kao KT, Denker M, Zacharin M, Wong SC. Pubertal abnormalities in adolescents with chronic disease. Best Pract Res Clin Endocrinol Metab. 2019;33(3):101275.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1032_CR5","doi-asserted-by":"crossref","unstructured":"Amaro F, Chiarelli F. Growth and puberty in children with inflammatory bowel diseases. Biomedicines. 2020;8(11).","DOI":"10.3390\/biomedicines8110458"},{"issue":"2","key":"1032_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.6065\/apem.2018.23.2.57","volume":"23","author":"M Bozzola","year":"2018","unstructured":"Bozzola M, Bozzola E, Montalbano C, Stamati FA, Ferrara P, Villani A. Delayed puberty versus hypogonadism: a challenge for the pediatrician. Ann Pediatr Endocrinol Metab. 2018;23(2):57\u201361.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"1032_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/apt.13478","volume":"43","author":"M Fumery","year":"2016","unstructured":"Fumery M, Duricova D, Gower-Rousseau C, Annese V, Peyrin-Biroulet L, Lakatos PL. Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies. Aliment Pharmacol Ther. 2016;43(3):346\u201355.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1032_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12887-021-02496-4","volume":"21","author":"HY Jin","year":"2021","unstructured":"Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, et al. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr. 2021;21(1):35.","journal-title":"BMC Pediatr"},{"issue":"2","key":"1032_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MPG.0000000000003667","volume":"76","author":"MV Salguero","year":"2023","unstructured":"Salguero MV, Deplewski D, Gokhale R, Wroblewski K, Sentongo T, Jan A, et al. Growth after menarche in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2023;76(2):183\u201390.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"1032_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/ibd\/izaa023","volume":"26","author":"N Gupta","year":"2020","unstructured":"Gupta N, Lustig RH, Andrews H, Sylvester F, Keljo D, Goyal A, et al. Introduction to and screening visit results of the multicenter pediatric crohn\u2019s disease growth study. Inflamm Bowel Dis. 2020;26(12):1945\u201350.","journal-title":"Inflamm Bowel Dis"},{"key":"1032_CR11","unstructured":"Prevention CfDCa. Center for Disease Control growth charts: United States 2000 Available from: http:\/\/www.cdc.gov\/growthcharts\/"},{"issue":"2","key":"1032_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1203\/00006450-200302000-00002","volume":"53","author":"AB Ballinger","year":"2003","unstructured":"Ballinger AB, Savage MO, Sanderson IR. Delayed puberty associated with inflammatory bowel disease. Pediatr Res. 2003;53(2):205\u201310.","journal-title":"Pediatr Res"},{"key":"1032_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/epirev\/mxt009","volume":"36","author":"H Ju","year":"2014","unstructured":"Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104\u201313.","journal-title":"Epidemiol Rev"},{"issue":"7","key":"1032_CR14","first-page":"Cd001751","volume":"2015","author":"J Marjoribanks","year":"2015","unstructured":"Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;2015(7):Cd001751.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1032_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/MIB.0b013e318281f3a9","volume":"19","author":"S Saha","year":"2013","unstructured":"Saha S, Midtling E, Roberson E, Nair VA, Wald A, Reichelderfer M. Dysmenorrhea in women with crohn\u2019s disease: a case-control study. Inflamm Bowel Dis. 2013;19(7):1463\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"1032_CR16","doi-asserted-by":"crossref","unstructured":"Schoenberger H, Chen C, Sampene E et al. Dysmenorrhea in women with ulcerative colitis. Crohn\u2019s & Colitis Congress Abstract P080. 2019.","DOI":"10.1053\/j.gastro.2019.01.140"},{"issue":"6","key":"1032_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jpag.2016.04.002","volume":"29","author":"CN Davis-Kankanamge","year":"2016","unstructured":"Davis-Kankanamge CN, Bercaw-Pratt JL, Santos XM, Dietrich JE. Crohn\u2019s disease and gynecologic manifestations in young women. J Pediatr Adolesc Gynecol. 2016;29(6):582\u20134.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"1032_CR18","doi-asserted-by":"publisher","first-page":"175628482092980","DOI":"10.1177\/1756284820929806","volume":"13","author":"A Lahat","year":"2020","unstructured":"Lahat A, Falach-Malik A, Haj O, Shatz Z, Ben-Horin S. Change in bowel habits during menstruation: are IBD patients different? Th Adv Gastroenterol. 2020;13:1756284820929806.","journal-title":"Th Adv Gastroenterol"},{"issue":"3","key":"1032_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/01.MIB.0000441347.94451.cf","volume":"20","author":"S Saha","year":"2014","unstructured":"Saha S, Zhao YQ, Shah SA, Esposti SD, Lidofsky S, Salih S, et al. Menstrual cycle changes in women with inflammatory bowel disease: a study from the ocean state crohn\u2019s and colitis area registry. Inflamm Bowel Dis. 2014;20(3):534\u201340.","journal-title":"Inflamm Bowel Dis"},{"key":"1032_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejogrb.2020.06.051","volume":"252","author":"F Chiaffarino","year":"2020","unstructured":"Chiaffarino F, Cipriani S, Ricci E, Roncella E, Mauri PA, Parazzini F, et al. Endometriosis and inflammatory bowel disease: A systematic review of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;252:246\u201351.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1032_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5009\/gnl.2013.7.1.51","volume":"7","author":"SM Lim","year":"2013","unstructured":"Lim SM, Nam CM, Kim YN, Lee SA, Kim EH, Hong SP, et al. The effect of the menstrual cycle on inflammatory bowel disease: a prospective study. Gut Liver. 2013;7(1):51\u20137.","journal-title":"Gut Liver"},{"issue":"1","key":"1032_CR22","doi-asserted-by":"publisher","first-page":"otae078","DOI":"10.1093\/crocol\/otae078","volume":"7","author":"EJ Brenner","year":"2025","unstructured":"Brenner EJ, Grewe ME, Berenblum Tobi C, Bryant AG, Dubinsky MC, Zhang X, et al. Perspectives on Contraception, Pregnancy, and reproductive health counseling from young women with inflammatory bowel disease. Crohns Colitis 360. 2025;7(1):otae078.","journal-title":"Crohns Colitis 360"},{"issue":"10","key":"1032_CR23","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/j.1572-0241.1998.540_i.x","volume":"93","author":"SV Kane","year":"1998","unstructured":"Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998;93(10):1867\u201372.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1032_CR24","first-page":"250","volume":"14","author":"E Parlak","year":"2003","unstructured":"Parlak E, Da\u011fli U, Alkim C, Di\u015fibeyaz S, Tun\u00e7 B, Ulker A, et al. Pattern of Gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol. 2003;14(4):250\u20136.","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"1032_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/gastro\/gov010","volume":"3","author":"S Bharadwaj","year":"2015","unstructured":"Bharadwaj S, Barber MD, Graff LA, Shen B. Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle. Gastroenterol Rep (Oxf). 2015;3(3):185\u201393.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"7","key":"1032_CR26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1471-0528.1990.tb02545.x","volume":"97","author":"G Sundell","year":"1990","unstructured":"Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol. 1990;97(7):588\u201394.","journal-title":"Br J Obstet Gynaecol"},{"issue":"12","key":"1032_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/archpedi.154.12.1226","volume":"154","author":"C Banikarim","year":"2000","unstructured":"Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med. 2000;154(12):1226\u20139.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"1032_CR28","first-page":"323","volume":"21","author":"TP Ng","year":"1992","unstructured":"Ng TP, Tan NC, Wansaicheong GK. A prevalence study of dysmenorrhoea in female residents aged 15\u201354 years in Clementi Town, Singapore. Ann Acad Med Singap. 1992;21(3):323\u20137.","journal-title":"Ann Acad Med Singap"},{"issue":"11","key":"1032_CR29","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1089\/jwh.2023.0199","volume":"32","author":"E Fooladi","year":"2023","unstructured":"Fooladi E, Bell RJ, Robinson PJ, Skiba M, Davis SR. Dysmenorrhea, Workability, and absenteeism in Australian women. J Womens Health (Larchmt). 2023;32(11):1249\u201356.","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"1032_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ibd\/izx004","volume":"24","author":"VS Rolston","year":"2018","unstructured":"Rolston VS, Boroujerdi L, Long MD, McGovern DPB, Chen W, Martin CF, et al. The influence of hormonal fluctuation on inflammatory bowel disease symptom Severity-A Cross-Sectional cohort study. Inflamm Bowel Dis. 2018;24(2):387\u201393.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1032_CR31","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1097\/AOG.0000000000002978","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 760: dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol. 2018;132(6):e249\u201358.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1032_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1368-5031.2004.00179.x","volume":"58","author":"M Bitner","year":"2004","unstructured":"Bitner M, Kattenhorn J, Hatfield C, Gao J, Kellstein D. Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea. Int J Clin Pract. 2004;58(4):340\u20135.","journal-title":"Int J Clin Pract"},{"issue":"12","key":"1032_CR33","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1080\/03007995.2019.1654987","volume":"35","author":"SE Daniels","year":"2019","unstructured":"Daniels SE, Paredes-Diaz A, An R, Centofanti R, Tajaddini A. Significant, long-lasting pain relief in primary dysmenorrhea with low-dose Naproxen sodium compared with acetaminophen: a double-blind, randomized, single-dose, crossover study. Curr Med Res Opin. 2019;35(12):2139\u201347.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1032_CR34","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/j.ajog.2006.06.091","volume":"196","author":"MY Dawood","year":"2007","unstructured":"Dawood MY, Khan-Dawood FS. Clinical efficacy and differential Inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea. Am J Obstet Gynecol. 2007;196(1):e351\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1032_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0020-7292(85)90024-4","volume":"23","author":"I Milsom","year":"1985","unstructured":"Milsom I, Andersch B. Ibuprofen and naproxen-sodium in the treatment of primary dysmenorrhea: a double-blind cross-over study. Int J Gynaecol Obstet. 1985;23(4):305\u201310.","journal-title":"Int J Gynaecol Obstet"},{"issue":"19","key":"1032_CR36","doi-asserted-by":"publisher","first-page":"e19881","DOI":"10.1097\/MD.0000000000019881","volume":"99","author":"W Nie","year":"2020","unstructured":"Nie W, Xu P, Hao C, Chen Y, Yin Y, Wang L. Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea: A network meta-analysis. Medicine. 2020;99(19):e19881.","journal-title":"Medicine"},{"issue":"4","key":"1032_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/01443610802150051","volume":"28","author":"MI Nor Azlin","year":"2008","unstructured":"Nor Azlin MI, Maryasalwati I, Norzilawati MN, Mahdy ZA, Jamil MA, Zainul Rashid MR. The efficacy of Etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial. J Obstet Gynaecol. 2008;28(4):424\u20136.","journal-title":"J Obstet Gynaecol"},{"issue":"11","key":"1032_CR38","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/apt.14606","volume":"47","author":"OO Moninuola","year":"2018","unstructured":"Moninuola OO, Milligan W, Lochhead P, Khalili H. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of crohn\u2019s disease and ulcerative colitis exacerbation. Aliment Pharmacol Ther. 2018;47(11):1428\u201339.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"1032_CR39","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1097\/MIB.0000000000000165","volume":"20","author":"I Habib","year":"2014","unstructured":"Habib I, Mazulis A, Roginsky G, Ehrenpreis ED. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: pathophysiology and clinical associations. Inflamm Bowel Dis. 2014;20(12):2493\u2013502.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"1032_CR40","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.14309\/ajg.0000000000001932","volume":"117","author":"S Cohen-Mekelburg","year":"2022","unstructured":"Cohen-Mekelburg S, Van T, Wallace B, Berinstein J, Yu X, Lewis J, et al. The association between nonsteroidal Anti-Inflammatory drug use and inflammatory bowel disease exacerbations: A true association or residual bias? Am J Gastroenterol. 2022;117(11):1851\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1032_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","volume":"50","author":"MD Long","year":"2016","unstructured":"Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Role of nonsteroidal Anti-Inflammatory drugs in exacerbations of inflammatory bowel disease. J Clin Gastroenterol. 2016;50(2):152\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1032_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/hematology.2023000496","volume":"2023","author":"CT Cohen","year":"2023","unstructured":"Cohen CT, Powers JM. Intravenous iron therapy in pediatrics: who should get it and when is the right time? Hematol Am Soc Hematol Educ Program. 2023;2023(1):630\u20135.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"1032_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00431-020-03597-5","volume":"179","author":"V Mattiello","year":"2020","unstructured":"Mattiello V, Schmugge M, Hengartner H, von der Weid N, Renella R. Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG pediatric hematology working group. Eur J Pediatrics. 2020;179(4):527\u201345.","journal-title":"Eur J Pediatrics"},{"key":"1032_CR44","unstructured":"Mahadevan U, Seow CH, Barnes EL, Chaparro M, Flanagan E, Friedman S et al. Global consensus statement on the management of pregnancy in inflammatory bowel disease. J Crohn\u2019s Colitis. 2025;19(8)."},{"issue":"2","key":"1032_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MIB.0000000000000606","volume":"22","author":"LM Gawron","year":"2016","unstructured":"Gawron LM, Sanders J, Steele KP, Flynn AD. Reproductive planning and contraception for women with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(2):459\u201364.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1032_CR46","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","volume":"160","author":"U Mahadevan","year":"2021","unstructured":"Mahadevan U, Long MD, Kane SV, Roy A, Dubinsky MC, Sands BE, et al. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021;160(4):1131\u20139.","journal-title":"Gastroenterology"},{"key":"1032_CR47","doi-asserted-by":"crossref","unstructured":"Ott MA, Sucato GS, Leroy-Melamed M, Hoopes AJ. Adolescence Co. Contraceptive counseling and methods for adolescents: clinical report. Pediatrics. 2025;156(1).","DOI":"10.1542\/peds.2025-072218"},{"issue":"1","key":"1032_CR48","doi-asserted-by":"publisher","first-page":"otab083","DOI":"10.1093\/crocol\/otab083","volume":"4","author":"Z Picciarelli","year":"2022","unstructured":"Picciarelli Z, Stransky OM, Leech MM, Michel HK, Schwartz M, Kim SC, et al. Exploring reproductive health decision experiences and preferences of women with Pediatric-Onset inflammatory bowel diseases. Crohns Colitis 360. 2022;4(1):otab083.","journal-title":"Crohns Colitis 360"},{"key":"1032_CR49","doi-asserted-by":"crossref","unstructured":"Limdi JK, Rhodes S, Liu E, Kuriakose Kuzhiyanjal AJ, Brookes M, Farraye J et al. Knowledge, Values, and preferences regarding contraceptive choices among women living with inflammatory bowel disease. J Crohns Colitis. 2025;19(5).","DOI":"10.1093\/ecco-jcc\/jjae181"},{"key":"1032_CR50","doi-asserted-by":"crossref","unstructured":"Zapata LB, Snyder EM, Tepper NK, Curtis KM. Contraceptive use among women with inflammatory bowel disease: an updated systematic review. Contraception. 2025:111038.","DOI":"10.1016\/j.contraception.2025.111038"},{"issue":"24","key":"1032_CR51","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","volume":"326","author":"S Teal","year":"2021","unstructured":"Teal S, Edelman A. Contraception Selection, Effectiveness, and adverse effects: A review. JAMA. 2021;326(24):2507\u201318.","journal-title":"JAMA"},{"issue":"5","key":"1032_CR52","doi-asserted-by":"publisher","first-page":"e10061","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):e10061\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1032_CR53","first-page":"236","volume":"94","author":"S Hofmeister","year":"2016","unstructured":"Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2016;94(3):236\u201340.","journal-title":"Am Fam Physician"},{"issue":"10","key":"1032_CR54","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/ibd\/izz025","volume":"25","author":"JK Limdi","year":"2019","unstructured":"Limdi JK, Farraye J, Cannon R, Woodhams E, Farraye FA, Contraception. Venous Thromboembolism, and inflammatory bowel disease: what clinicians (and Patients) should know. Inflamm Bowel Dis. 2019;25(10):1603\u201312.","journal-title":"Inflamm Bowel Dis"},{"issue":"2 Pt 1","key":"1032_CR55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","volume":"122","author":"R Peragallo Urrutia","year":"2013","unstructured":"Peragallo Urrutia R, Coeytaux RR, McBroom AJ, Gierisch JM, Havrilesky LJ, Moorman PG, et al. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol. 2013;122(2 Pt 1):380\u20139.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"1032_CR56","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/apt.12294","volume":"37","author":"H Yuhara","year":"2013","unstructured":"Yuhara H, Steinmaus C, Corley D, Koike J, Igarashi M, Suzuki T, et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37(10):953\u201362.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9715","key":"1032_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657\u201363.","journal-title":"Lancet"},{"issue":"4","key":"1032_CR58","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.amsu.2015.10.020","volume":"4","author":"G Pellino","year":"2015","unstructured":"Pellino G, Sciaudone G, Caprio F, Candilio G, De Fatico GS, Reginelli A, et al. Hormonal contraceptives and venous thromboembolism: are inflammatory bowel disease patients at increased risk? A retrospective study on a prospective database. Ann Med Surg (Lond). 2015;4(4):462\u20136.","journal-title":"Ann Med Surg (Lond)"},{"issue":"10","key":"1032_CR59","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/1471-0528.14623","volume":"124","author":"N Lariv\u00e9e","year":"2017","unstructured":"Lariv\u00e9e N, Suissa S, Khosrow-Khavar F, Tagalakis V, Filion KB. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies. BJOG. 2017;124(10):1490\u20139.","journal-title":"BJOG"},{"issue":"5","key":"1032_CR60","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","volume":"156","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory bowel disease in pregnancy clinical care pathway: A report from the American gastroenterological association IBD parenthood project working group. Gastroenterology. 2019;156(5):1508\u201324.","journal-title":"Gastroenterology"},{"issue":"1","key":"1032_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","volume":"17","author":"J Torres","year":"2023","unstructured":"Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, et al. European crohn\u2019s and colitis guidelines on Sexuality, Fertility, Pregnancy, and lactation. J Crohns Colitis. 2023;17(1):1\u201327.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"1032_CR62","first-page":"1","volume":"73","author":"AT Nguyen","year":"2024","unstructured":"Nguyen AT, Curtis KM, Tepper NK, Kortsmit K, Brittain AW, Snyder EM, et al. U.S. Medical eligibility criteria for contraceptive Use, 2024. MMWR recommendations and reports: morbidity and mortality weekly report. Recommendations Rep. 2024;73(4):1\u2013126.","journal-title":"Recommendations Rep"},{"issue":"38","key":"1032_CR63","doi-asserted-by":"publisher","first-page":"e17309","DOI":"10.1097\/MD.0000000000017309","volume":"98","author":"YH Kim","year":"2019","unstructured":"Kim YH, Pfaller B, Marson A, Yim HW, Huang V, Ito S. The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: A systematic review and meta-analysis. Med (Baltim). 2019;98(38):e17309.","journal-title":"Med (Baltim)"},{"key":"1032_CR64","unstructured":"Brenner EJ, Zhang X, Long MD, Dubinsky MC, Kappelman MD. High use of Estrogen-based contraceptives in young women with inflammatory bowel disease in the united States. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2023."},{"issue":"6","key":"1032_CR65","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0016-5085(98)70419-6","volume":"114","author":"A Timmer","year":"1998","unstructured":"Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in crohn\u2019s disease. The Canadian Mesalamine for remission of crohn\u2019s disease study group. Gastroenterology. 1998;114(6):1143\u201350.","journal-title":"Gastroenterology"},{"issue":"1","key":"1032_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00004836-199207000-00005","volume":"15","author":"JP Wright","year":"1992","unstructured":"Wright JP. Factors influencing first relapse in patients with crohn\u2019s disease. J Clin Gastroenterol. 1992;15(1):12\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1032_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/gut.45.2.218","volume":"45","author":"J Cosnes","year":"1999","unstructured":"Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of crohn\u2019s disease: a prospective cohort study. Gut. 1999;45(2):218\u201322.","journal-title":"Gut"},{"issue":"1","key":"1032_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0010-7824(86)90032-6","volume":"33","author":"SF Grimmer","year":"1986","unstructured":"Grimmer SF, Back DJ, Orme ML, Cowie A, Gilmore I, Tjia J. The bioavailability of Ethinyloestradiol and levonorgestrel in patients with an ileostomy. Contraception. 1986;33(1):51\u20139.","journal-title":"Contraception"},{"issue":"2","key":"1032_CR69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0010-7824(85)90034-4","volume":"31","author":"LO Nilsson","year":"1985","unstructured":"Nilsson LO, Victor A, Kral JG, Johansson ED, Kock NG. Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy. Contraception. 1985;31(2):195\u2013204.","journal-title":"Contraception"},{"issue":"3","key":"1032_CR70","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.cgh.2012.10.022","volume":"11","author":"LE Targownik","year":"2013","unstructured":"Targownik LE, Bernstein CN, Nugent Z, Leslie WD. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. Clin Gastroenterol Hepatol. 2013;11(3):278\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1032_CR71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ajg.2016.537","volume":"112","author":"FA Farraye","year":"2017","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241\u201358.","journal-title":"Am J Gastroenterol"},{"key":"1032_CR72","doi-asserted-by":"crossref","unstructured":"Menon S, ADOLESCENCE CO, Alderman EM, Chung RJ, Grubb LK, Lee J et al. Long-Acting reversible contraception: specific issues for adolescents. Pediatrics. 2020;146(2).","DOI":"10.1542\/peds.2020-007252"},{"issue":"1","key":"1032_CR73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/AOG.0000000000005911","volume":"146","author":"Pain Management for In-Office Uterine and Cervical Procedures","year":"2025","unstructured":"Pain Management for In-Office Uterine and Cervical Procedures. ACOG clinical consensus 9. Obstet Gynecol. 2025;146(1):161\u201377.","journal-title":"Obstet Gynecol"},{"key":"1032_CR74","unstructured":"Buck E, McNally L, Vadakekut ES, Jenkins SM. Menstrual Suppression. StatPearls. Treasure Island (FL): StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC.; 2025."},{"issue":"10","key":"1032_CR75","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/ecco-jcc\/jjad079","volume":"17","author":"E Druvefors","year":"2023","unstructured":"Druvefors E, Myrelid P, Andersson RE, Landerholm K. Female and male fertility after colectomy and reconstructive surgery in inflammatory bowel diesase: A National cohort study from Sweden. J Crohns Colitis. 2023;17(10):1631\u20138.","journal-title":"J Crohns Colitis"},{"issue":"10s","key":"1032_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14309\/ajg.0000000000001963","volume":"117","author":"E Shmidt","year":"2022","unstructured":"Shmidt E, Dubinsky MC. Inflammatory bowel disease and pregnancy. Am J Gastroenterol. 2022;117(10s):60\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1032_CR77","doi-asserted-by":"crossref","unstructured":"Prentice RE, Wright EK, Flanagan E, Kamm MA, Goldberg R, Ross AL et al. Evaluation and management of ileal pouch-anal anastamosis (IPAA) complications in pregnancy, and the impacts of an IPAA on fertility. Eur J Gastroenterol Hepatol. 2023;35(5).","DOI":"10.1097\/MEG.0000000000002538"},{"issue":"9","key":"1032_CR78","first-page":"592","volume":"11","author":"E Rosenblatt","year":"2015","unstructured":"Rosenblatt E, Kane S. Sex-Specific issues in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2015;11(9):592\u2013601.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"10","key":"1032_CR79","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/ecco-jcc\/jjw078","volume":"10","author":"CP Selinger","year":"2016","unstructured":"Selinger CP, Ghorayeb J, Madill A. What factors might drive voluntary childlessness (VC) in women with IBD? Does IBD-specific Pregnancy-related knowledge matter? J Crohns Colitis. 2016;10(10):1151\u20138.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"1032_CR80","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ibd.20839","volume":"15","author":"R Mountifield","year":"2009","unstructured":"Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009;15(5):720\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1032_CR81","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ajg.2015.50","volume":"110","author":"FT Moller","year":"2015","unstructured":"Moller FT, Andersen V, Wohlfahrt J, Jess T. Familial risk of inflammatory bowel disease: a population-based cohort study 1977\u20132011. Am J Gastroenterol. 2015;110(4):564\u201371.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1032_CR82","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1111\/j.1572-0241.1999.01526.x","volume":"94","author":"M Orholm","year":"1999","unstructured":"Orholm M, Fonager K, S\u00f8rensen HT. Risk of ulcerative colitis and crohn\u2019s disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1999;94(11):3236\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"1032_CR83","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.crohns.2013.12.019","volume":"8","author":"R Mountifield","year":"2014","unstructured":"Mountifield R, Andrews JM, Bampton P. It IS worth the effort: patient knowledge of reproductive aspects of inflammatory bowel disease improves dramatically after a single group education session. J Crohns Colitis. 2014;8(8):796\u2013801.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"1032_CR84","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology. 2016;150(3):734\u2013e571.","journal-title":"Gastroenterology"},{"issue":"5","key":"1032_CR85","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1053\/j.gastro.2024.06.014","volume":"167","author":"S Kothari","year":"2024","unstructured":"Kothari S, Afshar Y, Friedman LS, Ahn J. AGA clinical practice update on Pregnancy-Related Gastrointestinal and liver disease: expert review. Gastroenterology. 2024;167(5):1033\u201345.","journal-title":"Gastroenterology"},{"issue":"9","key":"1032_CR86","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","volume":"14","author":"A de Lima","year":"2016","unstructured":"de Lima A, Zelinkova Z, Mulders AG, van der Woude CJ. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol. 2016;14(9):1285\u2013e921.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1032_CR87","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.dld.2023.08.054","volume":"56","author":"D Pugliese","year":"2024","unstructured":"Pugliese D, Privitera G, Gisbert JP, Chaparro M. New drugs for the treatment of IBD during conception, pregnancy, and lactation. Dig Liver Dis. 2024;56(2):235\u201341.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"1032_CR88","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","volume":"36","author":"A Forbes","year":"2017","unstructured":"Forbes A, Escher J, H\u00e9buterne X, K\u0142\u0119k S, Krznaric Z, Schneider S, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321\u201347.","journal-title":"Clin Nutr"},{"issue":"2","key":"1032_CR89","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jpn3.12096","volume":"78","author":"K Gerasimidis","year":"2024","unstructured":"Gerasimidis K, Russell RK, Giachero F, Gkikas K, Tel B, Assa A, et al. Precision nutrition in pediatric IBD: A position paper from the ESPGHAN special interest group for basic science and translational research, the IBD Porto group, and allied health professionals. J Pediatr Gastroenterol Nutr. 2024;78(2):428\u201345.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1032_CR90","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","volume":"48","author":"RM Lewis","year":"2021","unstructured":"Lewis RM, Laprise JF, Gargano JW, Unger ER, Querec TD, Chesson HW, et al. Estimated prevalence and incidence of Disease-Associated human papillomavirus types among 15- to 59-Year-Olds in the united States. Sex Transm Dis. 2021;48(4):273\u20137.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"1032_CR91","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"key":"1032_CR92","unstructured":"Group USCSW. U.S. Cancer Statistics Data Visualization Tool: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2025. Available from: https:\/\/www.cdc.gov\/cancer\/dataviz"},{"issue":"11","key":"1032_CR93","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/ecco-jcc\/jjv122","volume":"9","author":"KH Katsanos","year":"2015","unstructured":"Katsanos KH, Roda G, Brygo A, Delaporte E, Colombel JF. Oral cancer and oral precancerous lesions in inflammatory bowel diseases: A systematic review. J Crohns Colitis. 2015;9(11):1043\u201352.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"1032_CR94","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035","volume":"11","author":"A Wisniewski","year":"2017","unstructured":"Wisniewski A, Fl\u00e9jou JF, Siproudhis L, Abramowitz L, Svrcek M, Beaugerie L. Anal neoplasia in inflammatory bowel disease: classification Proposal, Epidemiology, Carcinogenesis, and risk management perspectives. J Crohns Colitis. 2017;11(8):1011\u20138.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"1032_CR95","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","volume":"21","author":"JR Allegretti","year":"2015","unstructured":"Allegretti JR, Barnes EL, Cameron A. Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis. Inflamm Bowel Dis. 2015;21(5):1089\u201397.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1032_CR96","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","volume":"103","author":"S Kane","year":"2008","unstructured":"Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(3):631\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1032_CR97","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","volume":"136","author":"H Singh","year":"2009","unstructured":"Singh H, Demers AA, Nugent Z, Mahmud SM, Kliewer EV, Bernstein CN. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology. 2009;136(2):451\u20138.","journal-title":"Gastroenterology"},{"key":"1032_CR98","doi-asserted-by":"crossref","unstructured":"Mann S, Jess T, Allin K, Elmahdi R. Risk of cervical cancer in inflammatory bowel disease: A Meta-Analysis of Population-Based studies. Clin Translational Gastroenterol. 2022;13(7).","DOI":"10.14309\/ctg.0000000000000513"},{"key":"1032_CR99","unstructured":"Petrosky EBJ, Hariri S, Chesson H, Curtis R, Mona S, Unger E, Markowitz L. Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices 2015 [updated March 27, 2015. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6411a3.htm"},{"issue":"8","key":"1032_CR100","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711\u201323.","journal-title":"N Engl J Med"},{"issue":"19","key":"1032_CR101","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMcp2108502","volume":"388","author":"LE Markowitz","year":"2023","unstructured":"Markowitz LE, Unger ER. Human papillomavirus vaccination. N Engl J Med. 2023;388(19):1790\u20138.","journal-title":"N Engl J Med"},{"issue":"7","key":"1032_CR102","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/MIB.0b013e318281341b","volume":"19","author":"DL Jacobson","year":"2013","unstructured":"Jacobson DL, Bousvaros A, Ashworth L, Carey R, Shrier LA, Burchett SK, et al. Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(7):1441\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"1032_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pvr.2017.06.002","volume":"4","author":"SM Garland","year":"2017","unstructured":"Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, et al. HPV vaccination of immunocompromised hosts. Papillomavirus Res. 2017;4:35\u20138.","journal-title":"Papillomavirus Res"},{"key":"1032_CR104","doi-asserted-by":"crossref","unstructured":"Holland KJ, Wilkinson TA, Phipps E, Slaven JE, Bennett WE. Jr. Vaccination rates and family barriers among children with inflammatory bowel disease. Crohn\u2019s Colitis 360. 2020;2(3).","DOI":"10.1093\/crocol\/otaa056"},{"issue":"1","key":"1032_CR105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jpag.2016.08.005","volume":"30","author":"AM Hofstetter","year":"2017","unstructured":"Hofstetter AM, Lappetito L, Stockwell MS, Rosenthal SL. Human papillomavirus vaccination of adolescents with chronic medical conditions: A National survey of pediatric subspecialists. J Pediatr Adolesc Gynecol. 2017;30(1):88\u201395.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"12","key":"1032_CR106","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/ibd.21667","volume":"17","author":"SK Wasan","year":"2011","unstructured":"Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17(12):2536\u201340.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1032_CR107","doi-asserted-by":"publisher","first-page":"2214054","DOI":"10.1080\/21645515.2023.2214054","volume":"19","author":"AH McKenzie","year":"2023","unstructured":"McKenzie AH, Shegog R, Savas LS, Healy CM, Shay LA, Preston S, et al. Parents\u2019 stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors. Hum Vaccin Immunother. 2023;19(1):2214054.","journal-title":"Hum Vaccin Immunother"},{"key":"1032_CR108","doi-asserted-by":"crossref","unstructured":"Harris JG, Harris LA, Olarte L, Elson EC, Moran R, Blowey DL et al. Improving Pneumococcal vaccination rates in High-risk children in specialty clinics. Pediatrics. 2022;149(4).","DOI":"10.1542\/peds.2020-031724"},{"issue":"7","key":"1032_CR109","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"UPST Force","year":"2018","unstructured":"Force UPST. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA. 2018;320(7):674\u201386.","journal-title":"JAMA"},{"key":"1032_CR110","unstructured":"Updated Cervical Cancer Screening Guidelines 2021 [updated April. 2021. Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/04\/updated-cervical-cancer-screening-guidelines"},{"issue":"8","key":"1032_CR111","doi-asserted-by":"publisher","first-page":"e2526709","DOI":"10.1001\/jamanetworkopen.2025.26709","volume":"8","author":"TL Amboree","year":"2025","unstructured":"Amboree TL, Montealegre JR, Damgacioglu H, Orr B, Wrangle J, Sonawane K, et al. County-Level cervical cancer screening coverage and differences in incidence and mortality. JAMA Netw Open. 2025;8(8):e2526709\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1032_CR112","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2017.19872","volume":"320","author":"JJ Kim","year":"2018","unstructured":"Kim JJ, Burger EA, Regan C, Sy S. Screening for cervical cancer in primary care: A decision analysis for the US preventive services task force. JAMA. 2018;320(7):706\u201314.","journal-title":"JAMA"},{"issue":"2","key":"1032_CR113","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/LGT.0000000000000866","volume":"29","author":"AB Moscicki","year":"2025","unstructured":"Moscicki AB, Flowers L, Huchko MJ, Long ME, MacLaughlin KL, Murphy J, et al. Updated review for guidelines for cervical cancer screening in immunosuppressed women without HIV infection. J Low Genit Tract Dis. 2025;29(2):168\u201379.","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"1032_CR114","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.14309\/ajg.0000000000003541","volume":"120","author":"FA Farraye","year":"2025","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR, Barnes EL, Limketkai BN, Caldera F, et al. ACG clinical guideline update: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2025;120(7):1447\u201373.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1032_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12905-021-01264-x","volume":"21","author":"A Kirubarajan","year":"2021","unstructured":"Kirubarajan A, Leung S, Li X, Yau M, Sobel M. Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review. BMC Womens Health. 2021;21(1):122.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1032_CR116","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1097\/MPG.0000000000002703","volume":"71","author":"HK Michel","year":"2020","unstructured":"Michel HK, Noll RB, Siripong N, Kim SC. Patterns of Primary, Specialty, urgent care, and emergency department care in children with inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 2020;71(1):e28\u201334.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1032_CR117","doi-asserted-by":"crossref","unstructured":"Chung RJ, Lee JB, Hackell JM, Alderman EM, ADOLESCENCE CO, PRACTICE CO et al. Confidentiality in the care of adolescents: policy statement. Pediatrics. 2024;153(5).","DOI":"10.1542\/peds.2024-066326"},{"issue":"4","key":"1032_CR118","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/MPG.0b013e3182841263","volume":"56","author":"LM Mackner","year":"2013","unstructured":"Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American society for pediatric Gastroenterology, Hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2013;56(4):449\u201358.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1032_CR119","doi-asserted-by":"crossref","unstructured":"Alderman EM, Breuner CC, ADOLESCENCE CO, Grubb LK, Powers ME, Upadhya K et al. Unique needs of the adolescent. Pediatrics. 2019;144(6).","DOI":"10.1542\/peds.2019-3150"},{"issue":"3","key":"1032_CR120","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jama.2024.24246","volume":"333","author":"BA Allison","year":"2025","unstructured":"Allison BA, Wilkinson TA, Maslowsky J. Adolescent-Centered sexual and reproductive health communication. JAMA. 2025;333(3):250\u20131.","journal-title":"JAMA"},{"issue":"6","key":"1032_CR121","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.amepre.2024.09.007","volume":"67","author":"SE Romer","year":"2024","unstructured":"Romer SE, Blum J, Borrero S, Crowley JM, Hart J, Magee MM, et al. Providing quality family planning services in the united states: recommendations of the U.S. Office of population affairs (Revised 2024). Am J Prev Med. 2024;67(6):S41\u201386.","journal-title":"Am J Prev Med"},{"key":"1032_CR122","doi-asserted-by":"publisher","first-page":"101435","DOI":"10.1016\/j.dcn.2024.101435","volume":"69","author":"J Maslowsky","year":"2024","unstructured":"Maslowsky J, Buss E, Wray-Lake L. The role (and limits) of developmental neuroscience in determining adolescents\u2019 autonomy rights: the case for reproductive and voting rights. Dev Cogn Neurosci. 2024;69:101435.","journal-title":"Dev Cogn Neurosci"},{"issue":"10","key":"1032_CR123","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/ecco-jcc\/jjab043","volume":"15","author":"S Fourie","year":"2021","unstructured":"Fourie S, Norton C, Jackson D, Czuber-Dochan W. These discussions aren\u2019t happening\u2019: experiences of people living with inflammatory bowel disease and talking about sexual Well-being with health care professionals. J Crohn\u2019s Colitis. 2021;15(10):1641\u20138.","journal-title":"J Crohn\u2019s Colitis"},{"key":"1032_CR124","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1016\/j.hctj.2023.100033","volume":"2","author":"S Reed","year":"2024","unstructured":"Reed S, Bugwadia AK, Dave S, Wilson HE, Ramesh P, Michel HK. Sexual and reproductive health considerations in the care of young adults with inflammatory bowel disease: A multidisciplinary conversation. Health Care Transitions. 2024;2:100033.","journal-title":"Health Care Transitions"},{"key":"1032_CR125","unstructured":"Health CfDCDoR. For Providers: Teens Visiting a Health Clinic 2024 [updated May 15. 2024. Available from: https:\/\/www.cdc.gov\/reproductive-health\/hcp\/teen-pregnancy-prevention\/clinic-visit.html"},{"issue":"18","key":"1032_CR126","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.jacc.2023.08.049","volume":"82","author":"MB Davis","year":"2023","unstructured":"Davis MB, Bello NA, Berlacher K, Harrington CM, Lin JP, Lindley KJ, et al. Cardiovascular fellowship training in Cardio-Obstetrics: JACC review topic of the week. J Am Coll Cardiol. 2023;82(18):1792\u2013803.","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-026-01032-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-026-01032-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-026-01032-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:13:14Z","timestamp":1781633594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-026-01032-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s11894-026-01032-7","relation":{},"ISSN":["1534-312X"],"issn-type":[{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}